EBERS at the EIC-EVONIK Corporate Day

EBERS’ CEO, Pedro Moreo, participated in the EIC-EVONIK Corporate Day that took place in the headquarters of Evonik in Essen on February 6, co-organized by the European Innovation Council and Evonik. It was a great opportunity to present the new organ preservation technology that EBERS is developing to representatives of the Health Care division and the corporate venture capital fund of Evonik and discuss about the technology and potential collaborations.

eic and evonik 35  
eicsummit4 eicsummit4

EBERS at the EIC Innovators Forum

EBERS’ CEO, Pedro Moreo, participated in the EIC Innovators’ Forum organized in Berlin on September 10 by the European Innovation Council. He had the opportunity to exchange experiences with other beneficiaries from the SME Instrument program and presented the pitch deck of EBERS in a specific session for medical technology in front a jury of specialized investors.


Normothermic system demo in Wuhan (China)

EBERS normothermic perfusion system was tested at the Liver Disease University Hospital in Wuhan (China) last October 15th to 21st. Five perfusion experiments were completed in whichg pig liver subjected to 30 minutes of warm ischaemia were perfused in our system in order to improve.


Entrepreneurship day at ITAINNOVA

Our CTO, Víctor Alastrué, was recently presenting EBERS's organ preservation project at Entrepreneurship day organized by ITAINNOVA.

Inauguracion IoT Blockchain Smart Lab 54 small

New distribution agreement for Japan

Last October the 10th, EBERS signed a distribution agreement in Japan with the firm AR Brown (http://www.arbrown.com/english/). AR Brown is a leading Japanese company with commercial activity in a variety of sectors including chemicals, pharmaceuticals, automobile, aerospace and biotechnology. With this new agreement, EBERS gains access to the thriving regenerative medicine market in Japan.